---
title: Research in the Peng Lab
layout: default
group: research
---
<div class="mx-auto" style="max-width: 600px; padding: 2rem 1rem;">

  <div style="text-align: center; margin-bottom: 2rem;">
    <img src="{{ '/static/img/logo/dna_methy.png' | relative_url }}" alt="dna methylation" style="max-width: 400px; width: 100%; height: auto;">
  </div>

  <div style="font-size: 0.95rem; line-height: 1.7;">
    <p style="margin-bottom: 1.5rem;">
      Credits of the image: DNA Methylation Guide, Active Motif
    </p>

    <p style="margin-bottom: 1.5rem;">
      Our research centers on the development and application of computational and statistical methods for analyzing large-scale biomedical data, with a focus on integrative multi-omics analysis. We design and implement bioinformatics pipelines for genomics, epigenomics, transcriptomics, and metabolomics data, emphasizing reproducibility, scalability, and rigorous quality control.
    </p>

    <p style="margin-bottom: 1.5rem;">
      A major component of our work involves epigenomic analysis, particularly DNA methylationâ€“based modeling and integrative frameworks that link epigenetic variation with gene expression, metabolic profiles, and clinical phenotypes. We apply population-scale and disease-focused study designs, leveraging high-throughput sequencing and array-based platforms to identify molecular signatures and biomarkers associated with aging, disease, and complex traits.
    </p>

    <p style="margin-bottom: 1.5rem;">
      Methodologically, our research integrates statistical modeling, data harmonization, and cross-modal data integration, often in collaboration with clinical and experimental teams. By combining robust computational workflows with translational study designs, our work aims to enable precise, interpretable, and clinically relevant insights from complex biomedical datasets at the Indiana University School of Medicine.
    </p>
  </div>

</div>